Natera (NTRA) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Natera Revenue Highlights

Latest Revenue (Y)

$1.08B

Latest Revenue (Q)

$439.76M

Main Segment (Y)

Product

Main Geography (Y)

United States

Natera Revenue by Period

Natera Revenue by Year

Date	Revenue	Change
2023-12-31	$1.08B	31.99%
2022-12-31	$820.22M	31.13%
2021-12-31	$625.49M	59.97%
2020-12-31	$391.00M	29.33%
2019-12-31	$302.33M	17.34%
2018-12-31	$257.65M	22.15%
2017-12-31	$210.94M	-2.83%
2016-12-31	$217.07M	14.04%
2015-12-31	$190.35M	19.50%
2014-12-31	$159.29M	188.72%
2013-12-31	$55.17M	-

Natera generated $1.08B in revenue during NA 2023, up 31.99% compared to the previous quarter, and up 420.16% compared to the same period a year ago.

Natera Revenue by Quarter

Date	Revenue	Change
2024-09-30	$439.76M	6.39%
2024-06-30	$413.35M	12.40%
2024-03-31	$367.74M	18.20%
2023-12-31	$311.11M	15.95%
2023-09-30	$268.31M	2.64%
2023-06-30	$261.40M	8.13%
2023-03-31	$241.76M	11.28%
2022-12-31	$217.25M	3.14%
2022-09-30	$210.64M	6.27%
2022-06-30	$198.20M	2.09%
2022-03-31	$194.13M	12.20%
2021-12-31	$173.03M	9.43%
2021-09-30	$158.12M	11.33%
2021-06-30	$142.03M	-6.76%
2021-03-31	$152.32M	35.54%
2020-12-31	$112.38M	14.50%
2020-09-30	$98.14M	13.50%
2020-06-30	$86.47M	-8.02%
2020-03-31	$94.01M	12.94%
2019-12-31	$83.24M	6.84%
2019-09-30	$77.91M	4.78%
2019-06-30	$74.36M	11.27%
2019-03-31	$66.82M	-0.21%
2018-12-31	$66.97M	2.58%
2018-09-30	$65.28M	3.51%
2018-06-30	$63.07M	1.17%
2018-03-31	$62.34M	15.95%
2017-12-31	$53.77M	-5.10%
2017-09-30	$56.66M	5.67%
2017-06-30	$53.62M	14.32%
2017-03-31	$46.90M	-4.86%
2016-12-31	$49.30M	-8.52%
2016-09-30	$53.89M	3.66%
2016-06-30	$51.98M	-16.02%
2016-03-31	$61.90M	16.99%
2015-12-31	$52.91M	17.79%
2015-09-30	$44.92M	-0.37%
2015-06-30	$45.09M	-4.95%
2015-03-31	$47.44M	-4.91%
2014-12-31	$49.88M	7.80%
2014-09-30	$46.27M	29.13%
2014-06-30	$35.84M	31.29%
2014-03-31	$27.30M	-

Natera generated $439.76M in revenue during Q3 2024, up 6.39% compared to the previous quarter, and up 168.23% compared to the same period a year ago.

Natera Revenue Breakdown

Natera Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Genetic testing services	$18.30M	-	-	-	-
Product	$1.07B	$797.31M	$567.15M	$367.21M	$269.88M
Licensing and other	$14.05M	$22.91M	$58.34M	-	-
Oncology products	$19.30M	-	-	-	-
Licensing And Other	-	-	-	$23.79M	$32.45M
Upfront License And Constellation And Paternity Services	-	-	-	-	$5.09M
Other Licensing And Other	-	-	-	-	$10.98M
License And Development Services	-	-	-	-	$16.38M

Natera's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (95.39%), Oncology products (1.72%), Genetic testing services (1.63%), and Licensing and other (1.25%).

Quarterly Revenue by Product

Product/Service	Sep 24	Mar 24	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19
Licensing and other	$3.63M	$3.07M	$6.94M	$3.15M	$3.96M	$4.36M	$10.81M	$3.62M	$4.13M	$12.14M	-	-	-	-	-	-	-	-	-	-
Product	$436.13M	$364.67M	$572.47M	$258.26M	$237.80M	$212.89M	$199.83M	$194.58M	$190.00M	$160.88M	$150.65M	$137.23M	$118.38M	$106.47M	$93.29M	$80.41M	$87.05M	$74.48M	$66.94M	$65.10M
Oncology products	-	-	-	$19.30M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Royalty	-	-	-	$20.00M	$600.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Licensing And Other	-	-	-	-	-	-	-	-	-	-	$7.46M	$4.79M	$33.93M	$5.91M	$4.86M	$6.06M	$6.97M	$8.76M	$10.97M	$9.26M
Other Licensing And Other Revenue	-	-	-	-	-	-	-	-	-	-	-	-	$10.00M	-	-	-	-	-	-	-
Other Licensing And Other	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$797.00K	$3.72M	$2.88M	$2.40M
License And Development Services	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$4.80M	-	-	-
Upfront License And Constellation And Paternity Services	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.37M	-	-	-
Panorama Nipt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$37.56M	$36.47M
Bgi Genomics Co Ltd	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$6.84M	$5.02M
Constellation	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.25M	$1.31M
Hcs	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$26.15M	$24.29M
Other Genetic Tests	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$3.23M	$4.35M
Qiagen	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$527.00K

Natera's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (99.17%), and Licensing and other (0.83%).

Natera Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Europe, Middle East, India, and Africa	$22.81M	$16.64M	$20.43M	-	-
Asia Pacific and Other	$7.22M	$14.03M	$10.14M	-	-
Americas, excluding U.S.	$4.91M	$3.71M	$4.05M	-	-
United States	$1.05B	$785.85M	$590.87M	-	-
Americas Excluding Us	-	-	-	$3.47M	$3.22M
Other Geographic Areas	-	-	-	$7.54M	$22.83M
U	-	-	-	$365.66M	$260.85M
Europe Middle East India And Africa	-	-	-	$14.33M	$15.43M

Natera's latest annual revenue breakdown by geography, as of Dec 23: United States (96.77%), Europe, Middle East, India, and Africa (2.11%), Asia Pacific and Other (0.67%), and Americas, excluding U.S. (0.45%).

Quarterly Revenue by Country

Country	Sep 24	Mar 24	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19
Americas, excluding U.S.	$2.00M	$1.48M	$2.54M	$1.21M	$1.16M	$1.28M	$1.16M	$530.00K	$741.00K	$995.00K	-	-	-	-	-	-	-	-	-	-
United States	$426.27M	$359.41M	$561.09M	$253.30M	$233.25M	$209.68M	$197.07M	$191.89M	$187.22M	$163.07M	-	-	-	-	-	-	-	-	-	-
Europe, Middle East, India, Africa	$7.72M	$5.18M	$5.62M	$5.20M	$4.96M	$3.74M	$3.69M	-	-	-	-	-	-	-	-	-	-	-	-	-
Asia Pacific and Other	$3.76M	$1.67M	$3.79M	$1.28M	$2.15M	$2.04M	$7.46M	$2.05M	$2.48M	$2.86M	-	-	-	-	-	-	-	-	-	-
Americas Excluding Us	-	-	-	-	-	-	-	-	-	-	$1.25M	$992.00K	$813.00K	$885.00K	$1.08M	$721.00K	$782.00K	$827.00K	$806.00K	$767.00K
E M E A	-	-	-	-	-	-	-	-	-	-	$5.60M	$4.26M	$4.46M	$3.52M	$3.58M	$3.48M	$3.50M	$4.32M	-	-
Other Geographic Areas	-	-	-	-	-	-	-	-	-	-	$3.24M	$1.96M	$2.09M	$3.08M	$27.00K	$1.41M	$3.02M	$5.47M	$8.77M	$6.88M
U	-	-	-	-	-	-	-	-	-	-	$148.03M	$134.81M	$144.96M	$104.66M	$93.51M	$80.76M	$86.73M	$73.33M	$64.84M	$62.39M

Natera's latest quarterly revenue breakdown by geography, as of Sep 24: United States (96.93%), Europe, Middle East, India, Africa (1.76%), Asia Pacific and Other (0.86%), and Americas, excluding U.S. (0.46%).

Natera Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
ILMN	Illumina	$4.50B	$1.08B
EXAS	Exact Sciences	$2.50B	$708.65M
QGEN	Qiagen	$1.97B	$458.80M
NTRA	Natera	$1.08B	$439.76M
NEOG	Neogen	$924.22M	$216.96M
NEO	NeoGenomics	$591.64M	$167.82M
GH	Guardant Health	$563.95M	$177.24M
TWST	Twist Bioscience	$312.97M	$81.46M
CDNA	CareDx	$280.32M	$82.88M
CSTL	Castle Biosciences	$219.79M	$85.78M
PSNL	Personalis	$73.48M	$22.58M
DRIO	DarioHealth	$20.35M	$6.25M
SERA	Sera Prognostics	$306.00K	$24.00K

NTRA Revenue FAQ

What is Natera’s yearly revenue?

Natera's yearly revenue for 2023 was $1.08B, representing an increase of 31.99% compared to 2022. The company's yearly revenue for 2022 was $820.22M, representing an increase of 31.13% compared to 2021. NTRA's yearly revenue for 2021 was $625.49M, representing an increase of 59.97% compared to 2020.

What is Natera’s quarterly revenue?

Natera's quarterly revenue for Q3 2024 was $439.76M, a 6.39% increase from the previous quarter (Q2 2024), and a 63.90% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $413.35M, a 12.40% increase from the previous quarter (Q1 2024), and a 58.13% increase year-over-year (Q2 2023). NTRA's quarterly revenue for Q1 2024 was $367.74M, a 18.20% increase from the previous quarter (Q4 2023), and a 52.11% increase year-over-year (Q1 2023).

What is Natera’s revenue growth rate?

Natera's revenue growth rate for the last 3 years (2021-2023) was 73.08%, and for the last 5 years (2019-2023) was 258.08%.

What are Natera’s revenue streams?

Natera's revenue streams in c 23 are Genetic testing services, Product, Licensing and other, and Oncology products. Genetic testing services generated $18.3M in revenue, accounting 1.63% of the company's total revenue Product generated $1.07B in revenue, accounting 95.39% of the company's total revenue, up 34.02% year-over-year. Licensing and other generated $14.05M in revenue, accounting 1.25% of the company's total revenue, down -38.69% year-over-year. Oncology products generated $19.3M in revenue, accounting 1.72% of the company's total revenue

What is Natera’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Natera was Product. This segment made a revenue of $1.07B, representing 95.39% of the company's total revenue.